A5013911687- Renal Diseases and Glomerulopathies
- Renal and Vascular Pathologies
- Hormonal Regulation and Hypertension
- Platelet Disorders and Treatments
- Central Venous Catheters and Hemodialysis
- Blood Pressure and Hypertension Studies
- Organ Donation and Transplantation
- Metabolism, Diabetes, and Cancer
- Adrenal and Paraganglionic Tumors
- Dialysis and Renal Disease Management
- Nephrotoxicity and Medicinal Plants
- Advanced X-ray and CT Imaging
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Liver Disease and Transplantation
- Electrolyte and hormonal disorders
- Peroxisome Proliferator-Activated Receptors
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Diabetes Treatment and Management
- Trace Elements in Health
- Systemic Lupus Erythematosus Research
- Drug-Induced Adverse Reactions
- Biomedical Research and Pathophysiology
- Metabolism and Genetic Disorders
- Pharmacological Effects and Toxicity Studies
- ATP Synthase and ATPases Research
Stanford University
2014-2022
Stanford Medicine
2022
Columbia University
2004-2008
NewYork–Presbyterian Hospital
2002
Euglycemic diabetic ketoacidosis is a rare but serious adverse effect of sodium-glucose cotransporter 2 (SGLT2) inhibitors. We present case woman in her 40s with type diabetes mellitus hospitalized for revascularization moyamoya disease who developed empagliflozin-associated euglycemic despite having stopped the medication before admission. Surgical stress, acute postoperative illness, and decreased carbohydrate intake are postulated to be contributing factors development ketosis this...
Background and objectives Dent disease is a rare X–linked disorder characterized by low molecular weight proteinuria often considered renal tubular disease. However, glomerulosclerosis was recently reported in several patients. Thus, histopathologic features were assessed, their association with kidney function assessed. Design, setting, participants, & measurements Clinical pathology reports slides (where available) collected from 30 boys men eight countries who had undergone clinical...
Both membranous glomerulopathy and acute interstitial nephritis have been reported to occur following treatment with non-steroidal anti-inflammatory drugs. We report the first cases of celecoxib (Celebrex), a selective COX-2 inhibitor. The rapid complete resolution both conditions discontinuation Celebrex strongly implicates this agent in disease pathogenesis. These enlarge spectrum potential renal toxicities COX-2-specific
Recently there has been interest in the role of CTLA-4 Ig therapy for nephrotic syndrome due to minimal change disease (MCD) and focal segmental glomerulosclerosis (FSGS).1,2 Although effects FSGS have mixed,1–3 is very limited information on effect (abatacept) MCD.1,4 There one report a child with relapsing MCD high levels urinary CD80 (also known as B7.1) which administration abatacept resulted rapid remission but subsequent relapse.
Background: Primary hyperaldosteronism is the most common cause of secondary hypertension, and part noninvasive diagnostic studies used to confirm diagnosis include biochemical computed tomography (CT) adrenal glands. If no adenomas are seen on imaging, invasive vein sampling, diagnose unilateral disease amenable surgery, limited cases with high pre-test probability. We developed a dedicated MRI protocol investigated whether surgically-treatable aldosterone-producing missed by CT could be...
SOCIETY OF CRITICAL CARE MEDICINE 34TH CONGRESS PHOENIX, ARIZONA, USA JANUARY 15-19, 2005: Poster Presentation: Case Reports
Resistant hypertension affects 8.9% to 33% of all persons with hypertension, and is associated higher risks death, major cardiovascular events, left ventricular hypertrophy, progressive kidney disease, cognitive impairment. Guidelines recommend diagnostic work-up for resistant including assessment the renal vasculature but rates studies in real-world practice are not well known. From a cohort patients (n = 4660) from 2008-2016 prior founding Stanford Hypertension Center, we quantified...